The role of YTHDF2 in propelling ovarian cancer development is also verified by the clinical observation that YTHDF2 is upregulated in ovarian cancer samples and negatively associated with prognosis (Fig. 4a, e, Supplementary Fig. 5). The gene discussed is YTHDF2; the disease is ovarian carcinoma.